Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.61 (
caspase-8
)
6,833
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have identified a novel pro-apoptotic p53 target gene named
CDIP
(Cell Death Involved p53-target). Inhibition of
CDIP
abrogates p53-mediated apoptotic responses, demonstrating that
CDIP
is an important p53 apoptotic effector.
CDIP
itself potently induces apoptosis that is associated with
caspase-8
cleavage, implicating the extrinsic cell death pathway in apoptosis mediated by
CDIP
. siRNA-directed knockdown of
caspase-8
results in a severe impairment of
CDIP
-dependent cell death. In investigating the potential involvement of extrinsic cell death pathway in
CDIP
-mediated apoptosis, we found that TNF-alpha expression tightly correlates with
CDIP
expression, and that inhibition of TNF-alpha signaling attenuates
CDIP
-dependent apoptosis. We also demonstrate that TNF-alpha is upregulated in response to p53 and p53 inducing genotoxic stress, in a
CDIP
-dependent manner. Consistently, knockdown of TNF-alpha impairs p53-mediated stress-induced apoptosis. Together, these findings support a novel p53 -->
CDIP
--> TNF-alpha apoptotic pathway that directs apoptosis after exposure of cells to genotoxic stress. Thus,
CDIP
provides a new link between p53-mediated intrinsic and death receptor-mediated extrinsic apoptotic signaling, providing a novel target for cancer therapeutics aimed at maximizing the p53 apoptotic response of cancer cells to drug therapy.
...
PMID:CDIP, a novel pro-apoptotic gene, regulates TNFalpha-mediated apoptosis in a p53-dependent manner. 1759 62